(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202506 | 202406 | % Var | 202506 | 202406 | % Var | 202503 | 202403 | % Var | |
| Sales | 54.00 | 30.28 | 78.34 | 54.00 | 30.28 | 78.34 | 149.97 | 151.88 | -1.26 |
| Other Income | 0.91 | 0.58 | 56.90 | 0.91 | 0.58 | 56.90 | 3.36 | 2.80 | 20.00 |
| PBIDT | 4.39 | 2.32 | 89.22 | 4.39 | 2.32 | 89.22 | 13.38 | 11.88 | 12.63 |
| Interest | 0.23 | 0.08 | 187.50 | 0.23 | 0.08 | 187.50 | 0.72 | 0.90 | -20.00 |
| PBDT | 4.16 | 2.24 | 85.71 | 4.16 | 2.24 | 85.71 | 12.66 | 10.98 | 15.30 |
| Depreciation | 0.28 | 0.28 | 0.00 | 0.28 | 0.28 | 0.00 | 1.10 | 1.12 | -1.79 |
| PBT | 3.88 | 1.96 | 97.96 | 3.88 | 1.96 | 97.96 | 11.56 | 9.86 | 17.24 |
| TAX | 0.85 | 0.49 | 73.47 | 0.85 | 0.49 | 73.47 | 2.87 | 2.39 | 20.08 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 | -0.01 | 700.00 |
| PAT | 3.03 | 1.47 | 106.12 | 3.03 | 1.47 | 106.12 | 8.69 | 7.47 | 16.33 |
| Equity | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 | 29.90 | 29.90 | 0.00 |
| PBIDTM(%) | 8.13 | 7.66 | 6.11 | 8.13 | 7.66 | 6.11 | 8.92 | 7.82 | 14.06 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: